Researchers at the University of Sussex, in collaboration with scientists from different institutes worldwide, have ...
Data analysis conducted in collaboration with a leading academic medical center shows that AI‑Immunology™ enables vaccine design also for the ...
A £6.9m clinical trial programme that aims to improve brain cancer treatment for patients in Yorkshire has been launched by a ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. While rare, malignant brain tumors often have poor outcomes Nearly half of all malignant ...
A novel glioblastoma therapy developed by Rosalind Franklin University Helix 51 incubator company UP Oncolytics showed encouraging preclinical results in two studies presented at the American ...
A new glioblastoma treatment showed tumour elimination and durable protection in a preclinical model. Discover what this ...
New ground-breaking brain cancer clinical trials designed to improve survival and quality of life will be available in ...
A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity ...
Milan G. Chheda, MD, received a nearly $1.5 million Kleberg Foundation grant to advance a Zika virus-based immunotherapy ...
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside ...
Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, ...
Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results